Screening children for early signs of type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study checks for specific blood markers (“islet autoantibodies”) to find children who may be at risk for developing type 1 diabetes later, before symptoms start. It’s mainly for children who have no known diabetes yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (and your child, when possible) must give informed consent before any study steps.
- Your child must be between 9 months and 5 years old at the first screening.
- Your child must not already have a known diagnosis of diabetes (type 1 or any other type).
- You must be willing to take part in the screening process as explained by the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early signs of long-term complications in children and teens who have type 1 diabetes for more than a year. It may help your clinic spot problems sooner, when treatment could be easier.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
This study tests a screening program that looks for early signs of type 1 diabetes in children ages 2 to 10. It aims to find kids at risk as early as possible so they can get care sooner.
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
This study screens very young infants (under 6 weeks old) to find those at high risk for type 1 diabetes. The goal is to identify babies who may be able to join future prevention trials.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.